Katamaran Industries

At Katamaran, we are building more than a drug discovery company—we are building a movement to democratize tomorrow's cures. Katamaran exists to unlock lifesaving treatments for the billions underserved by today’s pharmaceutical industry. Using AI, automation, and translational biology, we accelerate therapies for patients and diseases pharma has left behind. Three Pillars of Our Mission 1. Drug Discovery for the Forgotten Each year, hundreds of promising drugs are shelved — not due to failure, but lack of commercial viability. Katamaran gives these molecules a second chance, reviving and repositioning them using AI and high-relevance tumoroid/ organoid assays. We aim to reach patients with rare, neglected, or overlooked cancers. Inclusive Biology for Global Impact Drug discovery remains skewed toward data from limited geographies and populations. We are building a platform that reflects global genetic and biological diversity — advancing equitable and effective therapies for all. AI + Assays + Automation = Access Our tech platform — combining AI-driven discovery with patient-relevant tumoroid assays — is built to reduce the cost and time of drug development. By simulating and streamlining R&D with automation, we can unlock more cures, affordably, and deliver them faster. Join the Movement We are scientists, technologists, doctors and builders. Katamaran is where next-gen science meets global health impact. Join us in reshaping inclusive drug discovery for all.